Clinical Trial Update: A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating simufilam in subjects with hepatic impairment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency
• Liver Disease

Drugs mentioned

• Simufilam (simufilam)

Snippet

Sponsor: Cassava Sciences, Inc. | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED